Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity.
Zhong Z, Zhang M, Ning Y, Mao G, Li X, Deng Q, Chen X, Zuo D, Zhao X, Xie E, Wang H, Guo L, Li B, Xiao K, He X.
Zhong Z, et al. Among authors: li x, li b.
Sci Rep. 2022 Oct 26;12(1):18011. doi: 10.1038/s41598-022-22975-7.
Sci Rep. 2022.
PMID: 36289396
Free PMC article.